Comparative effectiveness of buprenorphine adherence with telemedicine vs. in-person for rural and urban patients
These findings suggest that telemedicine is a viable alternative to in-person visits, especially for patients living in rural areas, which should help guide future policies that preserve or increase access to buprenorphine in a manner that can reduce barriers for patients.
Authors
- Adam T. Wright (ORCID: https://orcid.org/0000-0001-6844-145X)
- Ashley A. Leech (ORCID: https://orcid.org/0000-0001-6795-929X)
- Kevin N. Griffith (ORCID: https://orcid.org/0000-0002-8304-8602)
- Andrew David Wiese (ORCID: https://orcid.org/0000-0002-0699-4224)
- Thomas S. Reese (ORCID: https://orcid.org/0000-0002-1081-1670)
- Nana Addo Padi‐Adjirackor (ORCID: https://orcid.org/0000-0002-8407-7333)
- Stephen W. Patrick (ORCID: https://orcid.org/0000-0001-6958-0371)
- Jessica S. Ancker (ORCID: https://orcid.org/0000-0002-3859-9130)
- Bryan D. Steitz (ORCID: https://orcid.org/0000-0003-2066-8692)
- Mauli V Shah (ORCID: https://orcid.org/0009-0003-0930-561X)
Institutions
- Emory University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of the American Pharmacists Association
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1016/j.japh.2024.102318
- Citations
- 2
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.09
Funders
- National Institutes of Health
- Agency for Healthcare Research and Quality
- National Institute on Drug Abuse